1. Home
  2. LUNG vs CULP Comparison

LUNG vs CULP Comparison

Compare LUNG & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • CULP
  • Stock Information
  • Founded
  • LUNG 1995
  • CULP 1972
  • Country
  • LUNG United States
  • CULP United States
  • Employees
  • LUNG N/A
  • CULP N/A
  • Industry
  • LUNG Industrial Specialties
  • CULP Textiles
  • Sector
  • LUNG Health Care
  • CULP Consumer Discretionary
  • Exchange
  • LUNG Nasdaq
  • CULP Nasdaq
  • Market Cap
  • LUNG 65.6M
  • CULP 54.5M
  • IPO Year
  • LUNG 2020
  • CULP N/A
  • Fundamental
  • Price
  • LUNG $1.59
  • CULP $4.62
  • Analyst Decision
  • LUNG Buy
  • CULP
  • Analyst Count
  • LUNG 7
  • CULP 0
  • Target Price
  • LUNG $7.66
  • CULP N/A
  • AVG Volume (30 Days)
  • LUNG 480.4K
  • CULP 18.7K
  • Earning Date
  • LUNG 10-29-2025
  • CULP 09-10-2025
  • Dividend Yield
  • LUNG N/A
  • CULP N/A
  • EPS Growth
  • LUNG N/A
  • CULP N/A
  • EPS
  • LUNG N/A
  • CULP N/A
  • Revenue
  • LUNG $90,549,000.00
  • CULP $207,391,000.00
  • Revenue This Year
  • LUNG $10.30
  • CULP $2.41
  • Revenue Next Year
  • LUNG $14.72
  • CULP $3.46
  • P/E Ratio
  • LUNG N/A
  • CULP N/A
  • Revenue Growth
  • LUNG 18.24
  • CULP N/A
  • 52 Week Low
  • LUNG $1.47
  • CULP $3.42
  • 52 Week High
  • LUNG $9.37
  • CULP $6.85
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 39.52
  • CULP 59.29
  • Support Level
  • LUNG $1.54
  • CULP $4.45
  • Resistance Level
  • LUNG $1.63
  • CULP $4.69
  • Average True Range (ATR)
  • LUNG 0.12
  • CULP 0.21
  • MACD
  • LUNG 0.02
  • CULP 0.02
  • Stochastic Oscillator
  • LUNG 12.90
  • CULP 74.31

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: